These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26588988)

  • 1. Down-regulation of LATS kinases alters p53 to promote cell migration.
    Furth N; Bossel Ben-Moshe N; Pozniak Y; Porat Z; Geiger T; Domany E; Aylon Y; Oren M
    Genes Dev; 2015 Nov; 29(22):2325-30. PubMed ID: 26588988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
    Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
    Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
    Yao F; Liu H; Li Z; Zhong C; Fang W
    Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LATS tumor suppressor: a new governor of cellular homeostasis.
    Visser S; Yang X
    Cell Cycle; 2010 Oct; 9(19):3892-903. PubMed ID: 20935475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
    Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
    Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Fer induces ROS levels accompanied by ATM and p53 activation in colon carcinoma cells.
    Makovski A; Yaffe E; Shpungin S; Nir U
    Cell Signal; 2012 Jul; 24(7):1369-74. PubMed ID: 22434045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
    Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
    J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
    Furth N; Aylon Y
    Cell Death Differ; 2017 Sep; 24(9):1488-1501. PubMed ID: 28644436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.
    Aylon Y; Ofir-Rosenfeld Y; Yabuta N; Lapi E; Nojima H; Lu X; Oren M
    Genes Dev; 2010 Nov; 24(21):2420-9. PubMed ID: 21041410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.
    Visser S; Yang X
    Gene; 2010 Jan; 449(1-2):22-9. PubMed ID: 19799973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.
    Chan EH; Nousiainen M; Chalamalasetty RB; Schäfer A; Nigg EA; Silljé HH
    Oncogene; 2005 Mar; 24(12):2076-86. PubMed ID: 15688006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).
    Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W
    Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling.
    Wiegman EM; Blaese MA; Loeffler H; Coppes RP; Rodemann HP
    Radiother Oncol; 2007 Jun; 83(3):289-95. PubMed ID: 17560675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor.
    Deng X; Ye D; Hua K; Song H; Luo Q; Munankarmy A; Liu D; Zhou B; Zheng W; Zhou X; Ji C; Wang X; Yu Y; Fang L
    Cell Death Dis; 2021 Aug; 12(9):810. PubMed ID: 34446703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME; Gagnon V; Parent S; Asselin E
    Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of genetic instability by gain-of-function p53 cancer mutants.
    Xu Y
    Oncogene; 2008 Jun; 27(25):3501-7. PubMed ID: 18223686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LATS2 is a tumor suppressor gene of malignant mesothelioma.
    Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
    Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
    Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
    BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interaction between ATM and radiation-activated phosphorylation of P53 and P21].
    Luo JL; Cao JP; Zhu W; Feng S; Sheng FJ; Zhu CY; Zheng SY
    Ai Zheng; 2005 Sep; 24(9):1059-63. PubMed ID: 16159425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.